{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:42:52Z","timestamp":1790545372739,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jinorgbio.2022.111986","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T02:57:27Z","timestamp":1662346647000},"page":"111986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A split \u03b2-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs"],"prefix":"10.1016","volume":"236","author":[{"given":"Samuel R.","family":"Hinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.S.","family":"Corpuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"McFarlane Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2022.111986_bb0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2018.07.012","article-title":"Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents","volume":"376","author":"Brabec","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0025","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.chemrev.8b00396","article-title":"Metal drugs and the anticancer immune response","volume":"119","author":"Englinger","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/21460","article-title":"Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins","volume":"399","author":"Ohndorf","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0045","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0055","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C8SC00428E","article-title":"Triple action Pt(IV) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance","volume":"9","author":"Petruzzella","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0060","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/ijc.22088","article-title":"Severe oxidatively damaged DNA after cisplatin treatment of cancer patients","volume":"119","author":"Siomek","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3892\/or.2013.2279","article-title":"Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation","volume":"29","author":"Astolfi","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jinorgbio.2011.09.030","article-title":"Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates","volume":"106","author":"Bergamo","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s007750100223","article-title":"Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media","volume":"6","author":"Malin\u00e1","year":"2001","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0080","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00775-011-0806-7","article-title":"Ru binding to RNA following treatment with the antimetastatic prodrug NAMI-A in Saccharomyces cerevisiae and in vitro","volume":"16","author":"Hostetter","year":"2011","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jinorgbio.2018.02.019","article-title":"Ruthenium anticancer agent KP1019 binds more tightly than NAMI-A to tRNA Phe","volume":"182","author":"Dwyer","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0095","series-title":"In Vitro and In Vivo Evaluation of Ruthenium(II)-Arene PTA Complexes","author":"Scolaro","year":"2005"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0100","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00775-008-0400-9","article-title":"The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways","volume":"13","author":"Chatterjee","year":"2008","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0105","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1021\/acs.inorgchem.7b00915","article-title":"New class of half-sandwich ruthenium(II) arene complexes bearing the water-soluble CAP ligand as an in vitro anticancer agent","volume":"56","author":"Guerriero","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10637-014-0179-1","article-title":"Phase I\/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy","volume":"33","author":"Leijen","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","article-title":"From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)","volume":"100","author":"Hartinger","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0120","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ejic.201600986","article-title":"Thirty years of the drug candidate NAMI-A and the myths in the field of ruthenium anticancer compounds: a personal perspective","volume":"2017","author":"Alessio","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/srep07975","article-title":"3D-DIP-Chip: a microarray-based method to measure genomic DNA damage","volume":"5","author":"Powell","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0130","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1073\/pnas.1614430113","article-title":"Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution","volume":"113","author":"Hu","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0135","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1002\/anie.201607380","article-title":"Base-resolution analysis of cisplatin\u2013DNA adducts at the genome scale","volume":"55","author":"Shu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2019.118984","article-title":"Tracking the cellular targets of platinum anticancer drugs: current tools and emergent methods","volume":"498","author":"Sutton","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08290-2","article-title":"Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs","volume":"10","author":"Yimit","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0150","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.1021\/ja051969w","article-title":"DNA sequence-enabled reassembly of the green fluorescent protein","volume":"127","author":"Stains","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0155","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1021\/bi0517032","article-title":"Sequence-enabled reassembly of \u03b2-lactamase (SEER-LAC): a sensitive method for the detection of double-stranded DNA","volume":"45","author":"Ooi","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0160","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1021\/ja7114579","article-title":"A general and rapid cell-free approach for the interrogation of protein-protein, protein-DNA, and protein-RNA interactions and their antagonists utilizing split-protein reporters","volume":"130","author":"Porter","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0165","series-title":"Split \u03b2-Lactamase Sensor for the Sequence-Specific Detection of DNA Methylation","author":"Porter","year":"2007"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0170","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1021\/ja1116606","article-title":"Turn-on DNA damage sensors for the direct detection of 8-oxoguanine and photoproducts in native DNA","volume":"133","author":"Furman","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.drudis.2015.11.004","article-title":"Split protein biosensor assays in molecular pharmacological studies","volume":"21","author":"Wehr","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0180","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1021\/bi9709452","article-title":"DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA","volume":"36","author":"Dunham","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0185","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/bi026972w","article-title":"Nature of full-length HMGB1 binding to cisplatin-modified DNA","volume":"42","author":"Jung","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0190","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/bi026695t","article-title":"Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein","volume":"42","author":"Kasparkova","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0969-2126(98)00047-1","article-title":"High-resolution structures of variant Zif268-DNA complexes: implications for understanding zinc finger-DNA recognition","volume":"6","author":"Elrod-Erickson","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jmb.2006.08.016","article-title":"Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA","volume":"363","author":"Segal","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0205","author":"Reuter"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-129","article-title":"RNAstructure: software for RNA secondary structure prediction and analysis","volume":"11","author":"Reuter","year":"2010","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0215","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/bi2000214","article-title":"Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA","volume":"50","author":"Park","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/ic00004a005","volume":"30","author":"Alessio","year":"1991","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0225","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1039\/b400952e","article-title":"Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl4(DMSO)(Im)], NAMI-A","volume":"4","author":"Ravera","year":"2004","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jinorgbio.2003.12.003","article-title":"The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation","volume":"98","author":"Bacac","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/MBD.1996.243","volume":"3","author":"Lipponer","year":"1996","journal-title":"Metal-Based Drugs"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0240","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0021-9258(17)41984-3","article-title":"The binding properties of two antitumor ruthenium(III) complexes to apotransferrin","volume":"269","author":"Kratz","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0245","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1021\/ic00273a018","article-title":"Synthesis, molecular structure, and tumor-inhibiting properties of imidazolium trans-bis(imidazole)tetrachlororuthenate(III) and its methyl-substituted derivatives","volume":"26","author":"Keppler","year":"1987","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0250","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1135\/cccc19611298","article-title":"Komplexverbindungen Des Rutheniums Mit F\u00fcnfz\u00e4hligen Heterocyclischen Basen II. Reaktionen Des Ruthenium(III)-Chlorids Mit Pyrazol Und Imidazol","volume":"26","author":"Kr\u00e1l\u00edk","year":"1961","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0255","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1039\/b104021a","article-title":"[Ru(\u03b76-p-cymene)Cl2(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells","author":"Allardyce","year":"2001","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0260","doi-asserted-by":"crossref","DOI":"10.1128\/aem.63.6.2421-2431.1997","article-title":"Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain","author":"Roth","year":"1997","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0265","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gnh101","article-title":"Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications","author":"Zipper","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(02)71040-4","article-title":"DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair","volume":"71","author":"Brabec","year":"2002","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0275","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1021\/ja104395b","article-title":"Toward a general approach for RNA-templated hierarchical assembly of split-proteins","volume":"132","author":"Furman","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0280","first-page":"7100","article-title":"Free energy analysis and mechanism of base pair stacking in nicked DNA","volume":"44","author":"H\u00e4se","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0285","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx200","article-title":"Orientation-dependent FRET system reveals differences in structures and flexibilities of nicked and gapped DNA duplexes","volume":"45","author":"Kashida","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0290","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1021\/ac2015239","article-title":"Evaluating the global CpG methylation status of native DNA utilizing a bipartite split-luciferase sensor","volume":"83","author":"Badran","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abbi.1999.1654","article-title":"DNA as a possible target for antitumor ruthenium(III) complexes: a spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium(III) complexes with DNA","volume":"376","author":"Gallori","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0300","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s007750100223","article-title":"Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media","volume":"6","author":"Malin\u00e1","year":"2001","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/ic048967h","article-title":"Reactions of potent antitumor complex trans-[RuIIICl4(indazole)2]\u2212 with a DNA-relevant nucleobase and thioethers: insight into biological action","volume":"44","author":"Egger","year":"2005","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0310","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.biochi.2009.03.017","article-title":"Unusual DNA binding modes for metal anticancer complexes","volume":"91","author":"Pizarro","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00775-010-0635-0","article-title":"Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry","volume":"15","author":"Groessl","year":"2010","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0320","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11224-019-01439-1","article-title":"Effect of axial ligands on the mechanisms of action of Ru(III) complexes structurally similar to NAMI-A: a DFT study","volume":"31","author":"Shah","year":"2020","journal-title":"Struct. Chem."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0325","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1039\/C6DT03356C","article-title":"\u201cHead-to-head\u201d double-hamburger-like structure of di-ruthenated d(GpG) adducts of mono-functional Ru-arene anticancer complexes","volume":"45","author":"Liu","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4462","article-title":"Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity","volume":"5","author":"Adhireksan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0335","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq1214","article-title":"A zinc finger protein array for the visual detection of specific DNA sequences for diagnostic applications","volume":"39","author":"Kim","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0340","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cbpa.2011.10.014","article-title":"Split-protein systems: beyond binary protein-protein interactions","volume":"15","author":"Shekhawat","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2022.111986_bb0345","series-title":"Version 1.3","author":"The PyMOL Molecular Graphics System","year":"2010"}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422002756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013422002756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:09:30Z","timestamp":1758985770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013422002756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":69,"alternative-id":["S0162013422002756"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111986","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A split \u03b2-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2022.111986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111986"}}